Ameriprise’s Rockwell Medical RMTI Stock Holding History

Ameriprise’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,830	Closed	-$126K	–	4170
2025 Q2	$126K	Sell	14,830 -9	-0.1%	-$92	﹤0.01%	3866
2025 Q1	$168K	Sell	14,839 -7,357	-33%	-$133K	﹤0.01%	3814
2024 Q4	$453K	Sell	22,196 -38	-0.2%	-$1.11K	﹤0.01%	3558
2024 Q3	$883K	Buy	+22,234	New	+$598K	﹤0.01%	3271
2021 Q3	–	Sell	-95	Closed	-$10K	–	3942
2021 Q2	$10K	Sell	95 -3	-3%	-$310	﹤0.01%	3879
2021 Q1	$13K	Buy	+98	New	+$14.5K	﹤0.01%	3826
2015 Q3	–	Sell	-894	Closed	-$1.58M	–	3924
2015 Q2	$1.58M	Buy	+894	New	+$1.14M	﹤0.01%	2887
2014 Q2	–	Sell	-803	Closed	-$1.12M	–	5643
2014 Q1	$1.12M	Sell	803 -17	-2%	-$22.1K	﹤0.01%	2682
2013 Q4	$942K	Sell	820 -260	-24%	-$358K	﹤0.01%	2682
2013 Q3	$1.36M	Buy	1,080 +1,058	+4,809%	+$718K	﹤0.01%	2593
2013 Q2	$9K	Buy	+22	New	+$9.33K	﹤0.01%	4863

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Ameriprise's RMTI Position: Q3 2025 in Review

Ameriprise sold out of Rockwell Medical (RMTI) in Q3 2025, closing a stake of 14,830 shares — an estimated $126K sold.

Ameriprise first reported a position in RMTI in Q2 2013 and held it in 11 quarters. The position peaked at $1.58M in Q2 2015. 36 funds tracked by Wall St. Rank hold RMTI as of Q3 2025.

Ameriprise reported no remaining Rockwell Medical position as of Q3 2025 after selling out during the quarter.
Ameriprise sold 14,830 Rockwell Medical shares in Q3 2025, an estimated $126K.
Ameriprise first reported a position in Rockwell Medical in Q2 2013 and held it in 11 quarters.
Ameriprise's Rockwell Medical position peaked at $1.58M in Q2 2015.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2025.

Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.